Global Hemato Oncology Testing Market Report 2024

Hemato Oncology Testing Global Market Report 2023 – By Product And Services (Assay Kits And Reagents, Services), By Cancer Type (Leukemia, Lymphoma, Multiple Myeloma, Other Cancers), By Technology (Polymerase Chain Reaction (PCR), Immunohistochemistry (IHC), Next-Generation Sequencing (NGS), Other Technologies), By End User (Hospitals, Academic And Research Institutes, Other End Users) – Market Size, Trends, And Global Forecast 2023-2032

Starting Price : $5000.00 | Pages : 175 | Published : July 2023 | Delivery Time: 2-3 business days | Format : pdf

Need assistance or more information before the purchase?

Enquire Before Buying
Hemato Oncology Testing Global Market Report 2023

Proud Members Of

checkslacipN checkaoirsN checkscipN

Hemato oncology testing refers to a diagnostic test that is carried out to detect the presence of symptoms of blood disorders and blood cancers. These tests are used to diagnose anemia, infection, hemophilia, blood-clotting disorders, and leukemia.

The main products and services of hemato oncology testing are assay kits and reagents and services. Assay kits and reagents refer to instruments and chemicals that are used together to carry out analysis of certain substances. The cancer types involved are leukemia, lymphoma, multiple myeloma, and others which are tested by polymerase chain reaction (PCR), immunohistochemistry (IHC), next-generation sequencing (NGS), and other technologies by hospitals, academic and research institutes, and other end-users.

The global hemato oncology testing market is segmented -

1) By Product And Services: Assay Kits And Reagents, Services

2) By Cancer Type: Leukemia, Lymphoma, Multiple Myeloma, Other Cancers

3) By Technology: Polymerase Chain Reaction (PCR), Immunohistochemistry (IHC), Next-Generation Sequencing (NGS), Other Technologies

4) By End User: Hospitals, Academic And Research Institutes, Other End Users

The global hemato oncology testing market size is expected to grow from $2.79 billion in 2022 to $3.16 billion in 2023 at a compound annual growth rate (CAGR) of 13.14%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The global hemato oncology testing market size is expected to reach $5.24 billion in 2027 at a CAGR of 13.53%.

The increasing incidence of hematologic cancer is expected to drive the growth of the hemato oncology testing market going forward. Hematologic cancer refers to a group of cancers that originate in the blood and affect the blood, bone marrow, and lymphatic system and includes diseases such as leukemia, lymphoma, and myeloma. These diseases can be reduced with an early diagnosis which can be achieved using hemato oncology testing. For instance, in 2023, according to the American Cancer Society, a US-based voluntary health organization focusing on eliminating cancer, leukemia is estimated to affect 59,610 American and cause 23,710 deaths. Furthermore, new patients of non-Hodgkin lymphoma are expected to affect 80,550 people in the United States and cause 20,180 deaths. As a result, the increasing prevalence of hematologic cancers is propelling the hemato oncology market forward.

Major players in the hemato oncology testing market are F. Hoffmann-La Roche Ltd., Abbott Laboratories, Thermo Fisher Scientific Inc., Illumina Inc., Icon plc., Invivoscribe Inc., Qiagen N.V., Bio-Rad Laboratories Inc., Archerdx Inc., Arup Laboratories Inc., Asuragen Inc., Adaptive Biotechnologies Corp., Cepheid Inc., Entrogen Inc., CORE Diagnostics Inc., Genoptix Inc., GenPath Diagnostics, NeoGenomics Laboratories Inc. and Siemens AG.

Product innovations are a key trend gaining popularity in the hemato oncology testing market. Major companies operating in the hemato oncology testing market are introducing innovative products such as the Sysmex CLIA-validated liquid biopsy test to sustain their position in the market. For instance, in October 2021, Sysmex Inostics, a US-based biotechnology company launched a novel liquid biopsy test for the diagnosis of Minimal Residual Disease (MRD) in Acute Myeloid Leukaemia (AML). The new product leverages targeted Next Generation Sequencing (NGS) technology. The uniqueness of the product is that it is ultra-sensitive and detects even the slightest presence of cancer cells following initial therapy.

In January 2023, Merck & Co. Inc. a US-based pharmaceutical company acquired Imago BioSciences, Inc. for $1.35 billion. With this acquisition, Merck continued its strategy of investing in its pipeline to strengthen its presence in the field of hematology. Imago BioSciences Inc. is a US-based biotechnology company developing diagnostic and therapeutic products for hemato oncology testing and other blood-related disorders.

North America was the largest region in the hemato oncology testing market in 2022. Asia-Pacific is expected to be the fastest-growing region in the global hemato oncology testing market report during the forecast period. The regions covered in the global hemato oncology testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the hemato oncology testing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

The hemato oncology testing market consists of revenues earned by entities by providing sampling and diagnostic services. The market value includes the value of related goods sold by the service provider or included within the service offering. The hemato-oncology testing market also includes the sales of consumables and instruments which are used to provide hemato-oncology testing services. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

The hemato oncology testing market research report is one of a series of new reports from The Business Research Company that provides hemato oncology testing market statistics, including hemato oncology testing industry global market size, regional shares, competitors with hemato oncology testing market share, detailed hemato oncology testing market segments, market trends, and opportunities, and any further data you may need to thrive in the hemato oncology testing industry. This hemato oncology testing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

    Table Of Contents

    1. Executive Summary

    2. Hemato Oncology Testing Market Characteristics

    3. Hemato Oncology Testing Market Trends And Strategies

    4. Hemato Oncology Testing Market - Macro Economic Scenario

    4.1. COVID-19 Impact On Hemato Oncology Testing Market

    4.2. Ukraine-Russia War Impact On Hemato Oncology Testing Market

    4.3. Impact Of High Inflation On Hemato Oncology Testing Market

    5. Hemato Oncology Testing Market Size And Growth

    5.1. Global Hemato Oncology Testing Historic Market, 2017-2022, $ Billion

    5.1.1. Drivers Of The Market

    5.1.2. Restraints On The Market

    5.2. Global Hemato Oncology Testing Forecast Market, 2022-2027F, 2032F, $ Billion

    5.2.1. Drivers Of The Market

    5.2.2. Restraints On the Market

    6. Hemato Oncology Testing Market Segmentation

    6.1. Global Hemato Oncology Testing Market, Segmentation By Product And Services, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    Assay Kits And Reagents

    Services

    6.2. Global Hemato Oncology Testing Market, Segmentation By Cancer Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    Leukemia

    Lymphoma

    Multiple Myeloma

    Other Cancers

    6.3. Global Hemato Oncology Testing Market, Segmentation By Technology, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    Polymerase Chain Reaction (PCR)

    Immunohistochemistry (IHC)

    Next-Generation Sequencing (NGS)

    Other Technologies

    6.4. Global Hemato Oncology Testing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    Hospitals

    Academic And Research Institutes

    Other End Users

    7. Hemato Oncology Testing Market Regional And Country Analysis

    7.1. Global Hemato Oncology Testing Market, Split By Region, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    7.2. Global Hemato Oncology Testing Market, Split By Country, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    8. Asia-Pacific Hemato Oncology Testing Market

    8.1. Asia-Pacific Hemato Oncology Testing Market Overview

    Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

    8.2. Asia-Pacific Hemato Oncology Testing Market, Segmentation By Product And Services, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    8.3. Asia-Pacific Hemato Oncology Testing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    9. China Hemato Oncology Testing Market

    9.1. China Hemato Oncology Testing Market Overview

    9.2. China Hemato Oncology Testing Market, Segmentation By Product And Services, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion

    9.3. China Hemato Oncology Testing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion

    10. India Hemato Oncology Testing Market

    10.1. India Hemato Oncology Testing Market, Segmentation By Product And Services, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    10.2. India Hemato Oncology Testing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    11. Japan Hemato Oncology Testing Market

    11.1. Japan Hemato Oncology Testing Market, Segmentation By Product And Services, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    11.2. Japan Hemato Oncology Testing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    12. Australia Hemato Oncology Testing Market

    12.1. Australia Hemato Oncology Testing Market, Segmentation By Product And Services, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    12.2. Australia Hemato Oncology Testing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    13. Indonesia Hemato Oncology Testing Market

    13.1. Indonesia Hemato Oncology Testing Market, Segmentation By Product And Services, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    13.2. Indonesia Hemato Oncology Testing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    14. South Korea Hemato Oncology Testing Market

    14.1. South Korea Hemato Oncology Testing Market, Segmentation By Product And Services, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    14.2. South Korea Hemato Oncology Testing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    15. Western Europe Hemato Oncology Testing Market

    15.1. Western Europe Hemato Oncology Testing Market Overview

    15.2. Western Europe Hemato Oncology Testing Market, Segmentation By Product And Services, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    15.3. Western Europe Hemato Oncology Testing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    16. UK Hemato Oncology Testing Market

    16.1. UK Hemato Oncology Testing Market, Segmentation By Product And Services, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    16.2. UK Hemato Oncology Testing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    17. Germany Hemato Oncology Testing Market

    17.1. Germany Hemato Oncology Testing Market, Segmentation By Product And Services, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    17.2. Germany Hemato Oncology Testing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    18. France Hemato Oncology Testing Market

    18.4. France Hemato Oncology Testing Market, Segmentation By Product And Services, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    18.5. France Hemato Oncology Testing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    19. Eastern Europe Hemato Oncology Testing Market

    19.1. Eastern Europe Hemato Oncology Testing Market Overview

    19.2. Eastern Europe Hemato Oncology Testing Market, Segmentation By Product And Services, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    19.3. Eastern Europe Hemato Oncology Testing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    20. Russia Hemato Oncology Testing Market

    20.1. Russia Hemato Oncology Testing Market, Segmentation By Product And Services, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    20.2. Russia Hemato Oncology Testing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    21. North America Hemato Oncology Testing Market

    21.1. North America Hemato Oncology Testing Market Overview

    21.2. North America Hemato Oncology Testing Market, Segmentation By Product And Services, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    21.3. North America Hemato Oncology Testing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    22. USA Hemato Oncology Testing Market

    22.1. USA Hemato Oncology Testing Market Overview

    22.2. USA Hemato Oncology Testing Market, Segmentation By Product And Services, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    22.3. USA Hemato Oncology Testing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    23. South America Hemato Oncology Testing Market

    23.1. South America Hemato Oncology Testing Market Overview

    23.2. South America Hemato Oncology Testing Market, Segmentation By Product And Services, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    23.3. South America Hemato Oncology Testing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    24. Brazil Hemato Oncology Testing Market

    24.1. Brazil Hemato Oncology Testing Market, Segmentation By Product And Services, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    24.2. Brazil Hemato Oncology Testing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    25. Middle East Hemato Oncology Testing Market

    25.1. Middle East Hemato Oncology Testing Market Overview

    25.2. Middle East Hemato Oncology Testing Market, Segmentation By Product And Services, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    25.3. Middle East Hemato Oncology Testing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    26. Africa Hemato Oncology Testing Market

    26.1. Africa Hemato Oncology Testing Market Overview

    26.2. Africa Hemato Oncology Testing Market, Segmentation By Product And Services, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    26.3. Africa Hemato Oncology Testing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    27. Hemato Oncology Testing Market Competitive Landscape And Company Profiles

    27.1. Hemato Oncology Testing Market Competitive Landscape

    27.2. Hemato Oncology Testing Market Company Profiles

    27.2.1. F. Hoffmann-La Roche Ltd.

    27.2.1.1. Overview

    27.2.1.2. Products and Services

    27.2.1.3. Strategy

    27.2.1.4. Financial Performance

    27.2.2. Abbott Laboratories

    27.2.2.1. Overview

    27.2.2.2. Products and Services

    27.2.2.3. Strategy

    27.2.2.4. Financial Performance

    27.2.3. Thermo Fisher Scientific Inc.

    27.2.3.1. Overview

    27.2.3.2. Products and Services

    27.2.3.3. Strategy

    27.2.3.4. Financial Performance

    27.2.4. Illumina Inc.

    27.2.4.1. Overview

    27.2.4.2. Products and Services

    27.2.4.3. Strategy

    27.2.4.4. Financial Performance

    27.2.5. Icon plc.

    27.2.5.1. Overview

    27.2.5.2. Products and Services

    27.2.5.3. Strategy

    27.2.5.4. Financial Performance

    28. Key Mergers And Acquisitions In The Hemato Oncology Testing Market

    29. Hemato Oncology Testing Market Future Outlook and Potential Analysis

    30. Appendix

    30.1. Abbreviations

    30.2. Currencies

    30.3. Historic And Forecast Inflation Rates

    30.4. Research Inquiries

    30.5. The Business Research Company

    30.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2017-2022, $ Billion
  • Table 2: Global Forecast Market Growth, 2022-2027F, 2032F, $ Billion
  • Table 3: Global Hemato Oncology Testing Market, Segmentation By Product And Services, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 4: Global Hemato Oncology Testing Market, Segmentation By Cancer Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 5: Global Hemato Oncology Testing Market, Segmentation By Technology, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 6: Global Hemato Oncology Testing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 7: Global Hemato Oncology Testing Market, Split By Region, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 8: Global Hemato Oncology Testing Market, Split By Country, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 9: Asia-Pacific, Hemato Oncology Testing Market, Segmentation By Product And Services, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 10: Asia-Pacific, Hemato Oncology Testing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 11: China, Hemato Oncology Testing Market, Segmentation By Product And Services, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 12: China, Hemato Oncology Testing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 13: India, Hemato Oncology Testing Market, Segmentation By Product And Services, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 14: India, Hemato Oncology Testing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 15: Japan, Hemato Oncology Testing Market, Segmentation By Product And Services, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 16: Japan, Hemato Oncology Testing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 17: Australia, Hemato Oncology Testing Market, Segmentation By Product And Services, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 18: Australia, Hemato Oncology Testing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 19: Indonesia, Hemato Oncology Testing Market, Segmentation By Product And Services, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 20: Indonesia, Hemato Oncology Testing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 21: South Korea, Hemato Oncology Testing Market, Segmentation By Product And Services, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 22: South Korea, Hemato Oncology Testing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 23: Western Europe, Hemato Oncology Testing Market, Segmentation By Product And Services, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 24: Western Europe, Hemato Oncology Testing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 25: UK, Hemato Oncology Testing Market, Segmentation By Product And Services, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 26: UK, Hemato Oncology Testing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 27: Germany, Hemato Oncology Testing Market, Segmentation By Product And Services, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 28: Germany, Hemato Oncology Testing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 29: France, Hemato Oncology Testing Market, Segmentation By Product And Services, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 30: France, Hemato Oncology Testing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 31: Eastern Europe, Hemato Oncology Testing Market, Segmentation By Product And Services, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 32: Eastern Europe, Hemato Oncology Testing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 33: Russia, Hemato Oncology Testing Market, Segmentation By Product And Services, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 34: Russia, Hemato Oncology Testing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 35: North America, Hemato Oncology Testing Market, Segmentation By Product And Services, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 36: North America, Hemato Oncology Testing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 37: USA, Hemato Oncology Testing Market, Segmentation By Product And Services, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 38: USA, Hemato Oncology Testing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 39: South America, Hemato Oncology Testing Market, Segmentation By Product And Services, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 40: South America, Hemato Oncology Testing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 41: Brazil, Hemato Oncology Testing Market, Segmentation By Product And Services, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 42: Brazil, Hemato Oncology Testing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 43: Middle East, Hemato Oncology Testing Market, Segmentation By Product And Services, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 44: Middle East, Hemato Oncology Testing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 45: Africa, Hemato Oncology Testing Market, Segmentation By Product And Services, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 46: Africa, Hemato Oncology Testing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 47: F. Hoffmann-La Roche Ltd. Financial Performance
  • Table 48: Abbott Laboratories Financial Performance
  • Table 49: Thermo Fisher Scientific Inc. Financial Performance
  • Table 50: Illumina Inc. Financial Performance
  • Table 51: Icon plc. Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2017-2022, $ Billion
  • Figure 2: Global Forecast Market Growth, 2022-2027F, 2032F, $ Billion
  • Figure 3: Global Hemato Oncology Testing Market, Segmentation By Product And Services, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 4: Global Hemato Oncology Testing Market, Segmentation By Cancer Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 5: Global Hemato Oncology Testing Market, Segmentation By Technology, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 6: Global Hemato Oncology Testing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 7: Global Hemato Oncology Testing Market, Split By Region, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 8: Global Hemato Oncology Testing Market, Split By Country, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 9: Asia-Pacific, Hemato Oncology Testing Market, Segmentation By Product And Services, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 10: Asia-Pacific, Hemato Oncology Testing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 11: China, Hemato Oncology Testing Market, Segmentation By Product And Services, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 12: China, Hemato Oncology Testing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 13: India, Hemato Oncology Testing Market, Segmentation By Product And Services, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 14: India, Hemato Oncology Testing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 15: Japan, Hemato Oncology Testing Market, Segmentation By Product And Services, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 16: Japan, Hemato Oncology Testing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 17: Australia, Hemato Oncology Testing Market, Segmentation By Product And Services, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 18: Australia, Hemato Oncology Testing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 19: Indonesia, Hemato Oncology Testing Market, Segmentation By Product And Services, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 20: Indonesia, Hemato Oncology Testing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 21: South Korea, Hemato Oncology Testing Market, Segmentation By Product And Services, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 22: South Korea, Hemato Oncology Testing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 23: Western Europe, Hemato Oncology Testing Market, Segmentation By Product And Services, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 24: Western Europe, Hemato Oncology Testing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 25: UK, Hemato Oncology Testing Market, Segmentation By Product And Services, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 26: UK, Hemato Oncology Testing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 27: Germany, Hemato Oncology Testing Market, Segmentation By Product And Services, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 28: Germany, Hemato Oncology Testing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 29: France, Hemato Oncology Testing Market, Segmentation By Product And Services, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 30: France, Hemato Oncology Testing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 31: Eastern Europe, Hemato Oncology Testing Market, Segmentation By Product And Services, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 32: Eastern Europe, Hemato Oncology Testing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 33: Russia, Hemato Oncology Testing Market, Segmentation By Product And Services, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 34: Russia, Hemato Oncology Testing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 35: North America, Hemato Oncology Testing Market, Segmentation By Product And Services, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 36: North America, Hemato Oncology Testing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 37: USA, Hemato Oncology Testing Market, Segmentation By Product And Services, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 38: USA, Hemato Oncology Testing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 39: South America, Hemato Oncology Testing Market, Segmentation By Product And Services, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 40: South America, Hemato Oncology Testing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 41: Brazil, Hemato Oncology Testing Market, Segmentation By Product And Services, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 42: Brazil, Hemato Oncology Testing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 43: Middle East, Hemato Oncology Testing Market, Segmentation By Product And Services, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 44: Middle East, Hemato Oncology Testing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 45: Africa, Hemato Oncology Testing Market, Segmentation By Product And Services, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 46: Africa, Hemato Oncology Testing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 47: F. Hoffmann-La Roche Ltd. Financial Performance
  • Figure 48: Abbott Laboratories Financial Performance
  • Figure 49: Thermo Fisher Scientific Inc. Financial Performance
  • Figure 50: Illumina Inc. Financial Performance
  • Figure 51: Icon plc. Financial Performance
View Report
View Report
View Report
View Report
View Report
View Report
View Report
View Report